Detalhe da pesquisa
1.
Evidence that Extreme Dilutions of Paclitaxel and Docetaxel Alter Gene Expression of In Vitro Breast Cancer Cells.
Homeopathy
; 107(1): 32-39, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29528476
2.
Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness.
Sci Adv
; 9(26): eadf2860, 2023 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390209
3.
Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer.
Nat Commun
; 12(1): 2940, 2021 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34011995
4.
Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer.
Cancer Res
; 81(24): 6259-6272, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34711608
5.
Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer.
Cancer Cell
; 37(3): 387-402.e7, 2020 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32142667
6.
ESR1 alterations and metastasis in estrogen receptor positive breast cancer.
J Cancer Metastasis Treat
; 52019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31106278